Guest Editors
Zongsheng Guo, Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, UNITED STATES. E-mail: Zongsheng.Guo@RoswellPark.org
Wenxue Ma, Department of Medicine, Sanford Stem Cell Institute and Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA. wma@health.ucsd.edu
Summary
Cancer immunotherapy plays an important role in the treatment of cancer, leveraging the body's own immune system to identify and eradicate malignant cells. This revolutionary approach has shown remarkable success in various cancer types, offering new hope to patients worldwide.
This Special Issue focuses on the latest advancements in cancer immunotherapy, a rapidly evolving field that harnesses the body’s immune system to combat cancer. We invite researchers to submit original research articles, comprehensive reviews, and insightful case studies that explore innovative immunotherapeutic approaches, including immune checkpoint inhibitors, CAR T-cell therapy, cancer vaccines, and novel biomarkers. Contributions that address mechanisms of resistance, combination therapies, and translational research bridging laboratory findings to clinical applications are particularly encouraged. Our goal is to compile a diverse collection of pioneering studies that will drive forward the understanding and effectiveness of immunotherapy in oncology. Join us in advancing the fight against cancer through the power of the immune system.
Keywords
1. Cancer immunotherapy
2. Immune checkpoint inhibitors
3. CAR T-cell therapy
4. Cancer vaccines
5. Novel biomarkers
Published Papers
Login
Register
Submit a Paper
Propose a Special lssue